145 related articles for article (PubMed ID: 194981)
21. Oxidation-induced lymphocyte transformation.
O'Brien RL; Parker JW
Cell; 1976 Jan; 7(1):13-20. PubMed ID: 181137
[No Abstract] [Full Text] [Related]
22. Characterization of tumor binding by the IC-21 macrophage cell line.
Crawford EK; Latham PS; Shah EM; Hasday JD
Cancer Res; 1990 Aug; 50(15):4578-83. PubMed ID: 2164442
[TBL] [Abstract][Full Text] [Related]
23. Enhancement of selective tumor cell binding by activated murine macrophages in response to phorbol myristate acetate.
Somers SD; Adams DO
J Immunol; 1986 Mar; 136(6):2323-32. PubMed ID: 3512713
[TBL] [Abstract][Full Text] [Related]
24. Production of human lymphocyte mediators after activation with periodate or neuraminidase and galactose oxidase.
Greineder DK; Rocklin RE; David JR
J Immunol; 1979 Dec; 123(6):2804-7. PubMed ID: 227960
[TBL] [Abstract][Full Text] [Related]
25. Effect of inoculation with neuraminidase-treated tumor cells on macrophage cytotoxicity in vitro.
Alley CD; Snodgrass MJ
Cancer Res; 1978 Aug; 38(8):2332-8. PubMed ID: 667829
[No Abstract] [Full Text] [Related]
26. Carbohydrate surface constituents of T cells mediating delayed-type hypersensitivity that control entry into sites of antigen deposition.
Kaufmann SH; Schauer R; Hahn H
Immunobiology; 1981; 160(2):184-95. PubMed ID: 6274790
[TBL] [Abstract][Full Text] [Related]
27. Kinetics of hormone-induced tumor cell resistance to killing by antibody and complement.
Schlager SI; Ohanian SH; Borsos T
Cancer Res; 1977 Mar; 37(3):765-70. PubMed ID: 189914
[TBL] [Abstract][Full Text] [Related]
28. In vivo modulation of macrophage tumoricidal activity: enhanced tumor cell killing by peritoneal macrophages from mice given injections of sodium periodate.
Weinberg JB
J Natl Cancer Inst; 1981 Mar; 66(3):529-33. PubMed ID: 6259399
[TBL] [Abstract][Full Text] [Related]
29. Characterization of responding cells in oxidative mitogen stimulation. I. Ia+ cells and Ly-1+2+ cells are required for the proliferative response.
Phillips ML; Wettstein PJ; O'Brien RL; Parker JW; Frelinger JA
J Immunol; 1980 Jun; 124(6):2693-9. PubMed ID: 6246169
[TBL] [Abstract][Full Text] [Related]
30. Induction of lymphocyte transformation by sequential treatment with neuraminidase and galactose oxidase.
Novogrodsky A; Katchalski E
Proc Natl Acad Sci U S A; 1973 Jun; 70(6):1824-7. PubMed ID: 4352656
[TBL] [Abstract][Full Text] [Related]
31. Detection of cellular immunity to tumor antigens of a guinea pig hepatoma by inhibition of macrophage migration.
Churchill WH; Zbar B; Belli JA; David JR
J Natl Cancer Inst; 1972 Feb; 48(2):541-9. PubMed ID: 4119886
[No Abstract] [Full Text] [Related]
32. Effects of neoplasms on inflammation: depression of macrophage accumulation after tumor implantation.
Snyderman R; Pike MC; Blaylock BL; Weinstein P
J Immunol; 1976 Mar; 116(3):585-9. PubMed ID: 176265
[TBL] [Abstract][Full Text] [Related]
33. Detection of alloimmune memory cells by chemical modification of the cell surface with mitogenic oxidizing agents.
Suthanthiran M; Rubin AL; Novogrodsky A; Stenzel KH
Transplantation; 1980 Oct; 30(4):269-74. PubMed ID: 6255637
[TBL] [Abstract][Full Text] [Related]
34. Differential sensitivity of tumor targets to liver macrophage-mediated cytotoxicity.
Gardner CR; Wasserman AJ; Laskin DL
Cancer Res; 1987 Dec; 47(24 Pt 1):6686-91. PubMed ID: 3119198
[TBL] [Abstract][Full Text] [Related]
35. A diagnostic assay for the Wiskott-Aldrich syndrome and its variant forms.
Siminovitch KA; Greer WL; Novogrodsky A; Axelsson B; Somani AK; Peacocke M
J Investig Med; 1995 Apr; 43(2):159-69. PubMed ID: 7735919
[TBL] [Abstract][Full Text] [Related]
36. Characterization of macrophage recognition and killing of SV40-transformed tumor cells that are "resistant" or "susceptible" to contact-mediated killing.
Chapes SK; Duffin D; Paulsen AQ
J Immunol; 1988 Jan; 140(2):589-96. PubMed ID: 2826595
[TBL] [Abstract][Full Text] [Related]
37. Differential cytotoxicity of tumorigenic and nontumorigenic strain-2 guinea pig cells as mediated by syngeneic phytohemagglutinin-stimulated peritoneal exudate cells.
Zwilling BS; Meltzer MS; Evans CH
J Natl Cancer Inst; 1975 Mar; 54(3):743-7. PubMed ID: 1091742
[TBL] [Abstract][Full Text] [Related]
38. Detection of memory cells by chemical modification of the lymphocyte cell surface.
Stenzel KH; Suthanthiran M; Rubin AL; Novogrodsky A
Proc Eur Dial Transplant Assoc; 1979; 16():437-41. PubMed ID: 162003
[TBL] [Abstract][Full Text] [Related]
39. Marked stimulation of lymphocyte-mediated attack on tumor cells by target-directed liposomes containing immune RNA.
Magee WE; Cronenberger JH; Thor DE
Cancer Res; 1978 Apr; 38(4):1173-6. PubMed ID: 205346
[TBL] [Abstract][Full Text] [Related]
40. Lidocaine inhibits macrophage mediated cytotoxicity and enhances neutrophil mediated cytotoxicity.
Cameron DJ
Jpn J Exp Med; 1986 Dec; 56(6):265-9. PubMed ID: 3599491
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
